153 related articles for article (PubMed ID: 28549802)
1. Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2.
Lao K; Sun J; Wang C; Lyu W; Zhou B; Zhao R; Xu Q; You Q; Xiang H
Steroids; 2017 Aug; 124():29-34. PubMed ID: 28549802
[TBL] [Abstract][Full Text] [Related]
2. 6-Substituted 3,4-dihydro-naphthalene-2-carboxylic acids: synthesis and structure-activity studies in a novel class of human 5alpha reductase inhibitors.
Baston E; Salem OI; Hartmann RW
J Enzyme Inhib Med Chem; 2002 Oct; 17(5):303-20. PubMed ID: 12683747
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of novel androst-17β-amide structurally related compounds as dual 5α-reductase inhibitors and androgen receptor antagonists.
Lao K; Xun G; Gou X; Xiang H
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1597-1606. PubMed ID: 31469015
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel unsaturated carboxysteroids as human 5α-reductase inhibitors: a legitimate approach.
Aggarwal S; Thareja S; Bhardwaj TR; Haupenthal J; Hartmann RW; Kumar M
Eur J Med Chem; 2012 Aug; 54():728-39. PubMed ID: 22776417
[TBL] [Abstract][Full Text] [Related]
5. Activity of steroid 4 and derivatives 4a-4f as inhibitors of the enzyme 5α-reductase 1.
Arellano Y; Bratoeff E; Heuze Y; Bravo M; Soriano J; Cabeza M
Bioorg Med Chem; 2018 Aug; 26(14):4058-4064. PubMed ID: 30007568
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives as dual 5α-reductase inhibitors and androgen receptor antagonists.
Lao K; Sun J; Wang C; Wang Y; You Q; Xiao H; Xiang H
Bioorg Med Chem Lett; 2017 Sep; 27(17):4212-4217. PubMed ID: 28757062
[TBL] [Abstract][Full Text] [Related]
7. Novel dehydroepiandrosterone benzimidazolyl derivatives as 5α-reductase isozymes inhibitors.
Arellano Y; Bratoeff E; Segura T; Mendoza ME; Sánchez-Márquez A; Medina Y; Heuze Y; Soriano J; Cabeza M
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):908-14. PubMed ID: 26394987
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and activity of novel 16-dehydropregnenolone acetate derivatives as inhibitors of type 1 5α-reductase and on cancer cell line SK-LU-1.
Silva-Ortiz AV; Bratoeff E; Ramírez-Apan T; Heuze Y; Sánchez A; Soriano J; Cabeza M
Bioorg Med Chem; 2015 Dec; 23(24):7535-42. PubMed ID: 26631442
[TBL] [Abstract][Full Text] [Related]
9. Serenoa repens extracts: In vitro study of the 5α-reductase activity in a co-culture model for Benign Prostatic Hyperplasia.
Buonocore D; Verri M; Cattaneo L; Arnica S; Ghitti M; Dossena M
Arch Ital Urol Androl; 2018 Sep; 90(3):199-202. PubMed ID: 30362688
[TBL] [Abstract][Full Text] [Related]
10. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro effect of androstene derivatives as 5α-reductase type 1 enzyme inhibitors.
Bratoeff E; Sánchez A; Arellano Y; Heuze Y; Soriano J; Cabeza M
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1247-54. PubMed ID: 23051174
[TBL] [Abstract][Full Text] [Related]
12. New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors.
Arellano Y; Bratoeff E; Garrido M; Soriano J; Heuze Y; Cabeza M
Steroids; 2011 Nov; 76(12):1241-6. PubMed ID: 21729714
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor.
Yao Z; Xu Y; Zhang M; Jiang S; Nicklaus MC; Liao C
Bioorg Med Chem Lett; 2011 Jan; 21(1):475-8. PubMed ID: 21094046
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 3-tetrazolo steroidal analogs: Novel class of 5α-reductase inhibitors.
Aggarwal S; Mahapatra MK; Kumar R; Bhardwaj TR; Hartmann RW; Haupenthal J; Kumar M
Bioorg Med Chem; 2016 Feb; 24(4):779-88. PubMed ID: 26780831
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of N-substituted piperidine-4-(benzylidene-4-carboxylic acids) and evaluation as inhibitors of steroid-5alpha-reductase type 1 and 2.
Picard F; Baston E; Reichert W; Hartmann RW
Bioorg Med Chem; 2000 Jun; 8(6):1479-87. PubMed ID: 10896124
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biochemical evaluation of (carbamoylalkenyl)phenyloxy carboxylic acid derivatives as non-steroidal 5 alpha-reductase inhibitors.
Kattner L; Göhring S; Hartmann RW
Arch Pharm (Weinheim); 1995 Mar; 328(3):239-45. PubMed ID: 7539251
[TBL] [Abstract][Full Text] [Related]
17. New 5alpha-reductase inhibitors: in vitro and in vivo effects.
Pérez-Ornelas V; Cabeza M; Bratoeff E; Heuze I; Sánchez M; Ramírez E; Naranjo-Rodríguez E
Steroids; 2005 Mar; 70(3):217-24. PubMed ID: 15763601
[TBL] [Abstract][Full Text] [Related]
18. Exploration of Novel 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia by 2D/3D QSAR, Cytotoxicity Pre-ADME and Docking Studies.
Dhingra R; Malhotra M; Sharma V; Bhardwaj TR; Dhingra N
Curr Top Med Chem; 2018; 18(32):2816-2834. PubMed ID: 30659542
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors.
Bratoeff E; Cabeza M; Pérez-Ornelas V; Recillas S; Heuze I
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):275-81. PubMed ID: 18644453
[TBL] [Abstract][Full Text] [Related]
20. A review on steroidal 5α-reductase inhibitors for treatment of benign prostatic hyperplasia.
Sun J; Xiang H; Yang LL; Chen JB
Curr Med Chem; 2011; 18(23):3576-89. PubMed ID: 21756226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
